间歇性热量限制饮食对2型糖尿病缓解的影响:一项随机对照试验
本研究将38至72岁、2型糖尿病病程1至11年的患者按1:1随机分配至中国医学营养治疗(CMNT)组或对照组,评估间歇性禁食对糖尿病缓解的效果。3个月干预加3个月随访后,CMNT组缓解率47.2%(17/36),对照组2.8%(1/36),比值比31.32(95%CI 2.39-121.07,P<0.0001);12个月随访时44.4%(16/36)维持缓解。
要点
- CMNT组3个月干预加3个月随访后糖尿病缓解率为47.2%(17/36),对照组为2.8%(1/36)。
- CMNT组平均体重下降5.93 kg(SD 2.47),对照组下降0.27 kg(SD 1.43)。
- 12个月随访时44.4%(16/36)维持缓解,HbA1c为6.33%(SD 0.87)。
核心结论
- 本研究证明CMNT在实现至少1年糖尿病缓解方面具有临床疗效。
研究设计与样本
- 随机对照试验,将38至72岁、2型糖尿病病程1至11年、BMI 19.1至30.4、66.7%为男性、使用降糖药和/或胰岛素注射的参与者按1:1随机分配至中国医学营养治疗(CMNT)组或对照组。
主要发现
- 完成3个月干预加3个月随访后,CMNT组47.2%(17/36)参与者实现糖尿病缓解,对照组仅2.8%(1/36)实现缓解(比值比31.32;95%CI 2.39-121.07;P<0.0001)。
- CMNT组参与者平均体重下降5.93 kg(SD 2.47),对照组下降0.27 kg(SD 1.43)。
- 12个月随访后,44.4%(16/36)参与者维持缓解,HbA1c水平为6.33%(SD 0.87)。
- CMNT组药物费用较对照组低77.22%(60.4/月 vs 265.1/月)。
关键数值与推荐
- 糖尿病缓解定义为停用所有降糖药物后至少3个月内糖化血红蛋白A1c(HbA1c)稳定低于48 mmol/mol(<6.5%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The 2021 consensus report on the definition and interpretation of remission of type 2 diabetes (T2D) has been released. Although intermittent fasting diets (IF) are becoming very popular, no studies have investigated their benefit in diabetes remission. OBJECTIVE: The present study examined the effectiveness of IF in diabetes remission and potential remission durability. METHODS: Participants between ages 38 and 72 years with a duration of T2D of 1 to 11 years, a body mass index (BMI) of 19.1 to 30.4, 66.7% male, and antidiabetic agent use and/or insulin injection were randomly allocated at a ratio of 1:1 to the Chinese Medical Nutrition Therapy (CMNT) or control group. The primary outcome was diabetes remission, defined as a stable glycated hemoglobin A1c (HbA1c) level of less than 48 mmol/mol (< 6.5%) for at least 3 months after discontinuing all antidiabetic medications. The secondary outcomes included HbA1c level, fasting blood glucose level, blood pressure, weight, quality of life, and medication costs. We conducted a 12-month follow-up to assess the continuation of remission. RESULTS: On completing the 3-month intervention plus 3-month follow-up, 47.2% (17/36) of participants achieved diabetes remission in the CMNT group, whereas only 2.8% (1/36) of individuals achieved remission in the control group (odds ratio 31.32; 95% CI, 2.39-121.07; P < 0.0001). The mean body weight of participants in the CMNT group was reduced by 5.93 kg (SD 2.47) compared to 0.27 kg (1.43) in the control group. After the 12-month follow-up, 44.4% (16/36) of the participants achieved sustained remission, with an HbA1c level of 6.33% (SD 0.87). The medication costs of the CMNT group were 77.22% lower than those of the control group (60.4/month vs 265.1/month). CONCLUSION: This study demonstrated the clinical efficacy of CMNT in achieving diabetes remission for at least 1 year.
引用
- Yang X, Zhou J, Shao H, et al. Effect of an Intermittent Calorie-restricted Diet on Type 2 Diabetes Remission: A Randomized Controlled Trial. J Clin Endocrinol Metab. 2023. PMID: 36515429. doi:10.1210/clinem/dgac661
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。